Can presence of HLA type I and II alleles be associated with clinical spectrum of CHIKV infection?

• Published in: Transboundary and emerging diseases Vol. 69; no. 4; pp. e895 - e905
• Main Authors: Rueda, Juan C., Santos, Ana M., Angarita, Jose‐Ignacio, Saldarriaga, Eugenia‐Lucia, Peláez‐Ballestas, Ingris, Espinosa, Alejandro Silva, Briceño‐Balcázar, Ignacio, Arias‐Correal, Sofia, Arias‐Correal, Jose, Villota‐Erazo, Catalina, Reyes, Viviana, Bernal‐Macías, Santiago, Cardiel, Mario H., Londono, John
• Format: Journal Article
• Language: English
• Published: Berlin John Wiley & Sons, Inc 01.07.2022
• Subjects: abdomen; Alleles; Antigens; arbovirus; chikungunya; Chikungunya virus; Colombia; confidence interval; Confidence intervals; cross-sectional studies; disease susceptibility; Drb1 protein; face; Histocompatibility antigen HLA; HLA; HLA antigens; host-pathogen relationships; Immune response; immunogenetics; Infections; Leukocytes; odds ratio; pathophysiology; Patients; Population genetics; Signs and symptoms; Statistical analysis; Tissue typing; Vector-borne diseases; Virulence; Virulence factors
• ISSN: 1865-1674; 1865-1682; 1865-1682
• DOI: 10.1111/tbed.14387

Host immune response and virulence factors are key to disease susceptibility. However, there are no known association studies of human leukocyte antigen (HLA) class I and II alleles with chikungunya virus (CHIKV) infection in the Latin American population. Here, we aimed to identify HLA alleles present in patients with CHIKV infection versus healthy controls as well as the allelic association with the clinical spectrum of the disease. We conducted a cross‐sectional analysis of a community cohort and included patients aged 18 years and older with serologically confirmed CHIKV infection. HLA typing of HLA‐A, HLA‐B, and HLA‐DRB1 alleles was performed. Two‐by‐two tables were used to establish associations between allele presence and clinical characteristics. Data from 65 patients with confirmed CHIKV infection were analyzed for HLA typing. CHIKV infection was significantly associated with the presence of HLA‐A*68 [p = .005; odds ratio (OR): 8.90; 95% confidence interval (CI): 1.88–42.13], HLA‐B*35 (p = .03; OR: 2.01; 95% CI: 1.06–3.86), HLA‐DRB*01 (p <.001; OR: 5.70; 95% CI: 1.95–16.59), HLA‐DRB1*04 (p <.001; OR: 7.37; 95% CI: 3.33–16.30), and HLA‐DRB1*13 (p = .004; OR: 3.75; 95% CI: 1.50–9.39) alleles in patients versus healthy subjects. A statistically significant relationship was found between the presence of a rash on the face or abdomen and the presence of HLA‐DRB1*04 (p = .028; OR: 3.2; 95% CI: 1.11–9.15 and p = .007; OR: 4.33; 95% CI: 1.45–12.88, respectively). Our study demonstrated that, in our cohort, HLA type I and type II alleles are associated with CHIKV infection, and an HLA type II allele is associated with dermatological symptoms. Further research is needed to establish a path for future investigation of genes outside the HLA system to improve knowledge of the pathophysiology of CHIKV infection and its host–pathogen interaction.